ALTRIA GROUP, INC.

MO
Cigarettes
Last filing · Quarter 2 · Jun 30, 2026
Order

38 more quarters with Pro

ALTRIA GROUP, INC. back to 2009, every line as filed.

Create a free account
USD ($)
$ in Millions
Jun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016Mar 31, 2016Sep 30, 2015Jun 30, 2015Mar 31, 2015Sep 30, 2014Jun 30, 2014Mar 31, 2014Sep 30, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012Jun 30, 2012Mar 31, 2012Sep 30, 2011Jun 30, 2011Mar 31, 2011Sep 30, 2010Mar 31, 2010Sep 30, 2009
Cash Provided by (Used in) Operating Activities
                                                  
Net earnings - Consumer products
-
-
-
-
-
-
-
-
-
-
-
-
Net earnings (loss) - Financial services
-
-
-
-
-
-
-
-
-
-
-
-
Net earnings (losses)
2,298
2,183
2,375
2,378
1,077
2,293
3,803
2,129
2,166
2,117
1,787
224
Adjustments to reconcile net earnings to operating cash flows:
                                                  
Consumer products
                                                  
Depreciation and amortization
56
56
70
71
71
74
74
65
80
62
52
54
Deferred income tax provision (benefit)
(13)
46
(227)
7
26
15
582
(138)
(169)
(264)
(142)
(570)
Fair value adjustment for NJOY Transaction contingent payments, net of cash paid
-
0
-
-
25
-
140
-
-
-
-
-
Unrecognized tax benefit
-
-
291
-
0
(8)
55
33
1,173
-
-
-
(Income) losses from investments in equity securities
(87)
(158)
(107)
(148)
(143)
(116)
(119)
(295)
(58)
(127)
80
-
Dividends from ABI
186
-
-
181
-
-
139
-
-
163
-
-
Gain on the sale of IQOS System commercialization rights
-
-
0
0
-
0
(2,700)
-
-
-
-
-
Exit costs, net of cash paid
16
(5)
(5)
(4)
-
-
-
-
-
-
-
-
Impairment of goodwill
-
0
-
-
873
-
-
-
-
-
-
-
Asset impairment
-
-
-
-
-
0
354
-
-
-
-
-
(Income) losses from investments in equity securities
-
-
-
-
-
-
-
-
-
-
-
2,478
(Earnings) losses from equity investments
-
-
-
-
-
-
-
-
-
-
-
-
Loss on ABI/SABMiller business combination
-
-
-
-
-
-
-
-
-
-
-
-
Loss on Cronos-related financial instruments
-
-
-
-
-
-
-
-
0
0
0
0
Impairment of JUUL equity securities
-
-
-
-
-
-
-
-
-
-
-
-
Asset impairment and exit costs, net of cash paid
-
-
-
-
-
-
-
-
-
-
-
-
Loss on early extinguishment of debt
-
-
-
-
-
-
-
-
-
-
-
0
Gain on derivative financial instruments
-
-
-
-
-
-
-
-
-
-
-
-
I R S Payment Related To L I L O And S I L O Transactions
-
-
-
-
-
-
-
-
-
-
-
-
Exit costs, net of cash paid
-
-
-
-
-
-
-
-
-
-
-
-
Cash effects of changes:
                                                  
Receivables
(23)
(20)
(10)
18
(80)
(13)
5
(6)
77
(24)
(34)
(9)
Inventories
28
(76)
(49)
45
(18)
73
67
(26)
17
81
(72)
38
Accounts payable
(23)
(24)
93
13
(136)
(52)
45
(61)
35
33
(115)
20
Income taxes
(425)
610
137
(298)
565
219
(494)
671
(19)
(600)
409
43
Accrued liabilities and other current assets
343
(998)
(367)
(187)
(302)
(568)
26
(377)
(397)
556
(369)
(382)
Accrued liabilities and other current assets
-
-
-
-
-
-
-
-
-
-
-
-
Accrued settlement charges
(1,668)
659
789
(1,934)
678
798
(2,100)
857
826
(2,258)
895
982
Pension plan contributions
(4)
(4)
(2)
(4)
(5)
(4)
(5)
(4)
(3)
(4)
(7)
(3)
Pension and postretirement, net
(1)
(10)
(23)
(17)
(20)
(26)
(21)
(29)
(34)
(29)
(34)
(36)
Other, net
36
65
129
84
109
66
74
58
(742)
418
534
60
Pension provisions and postretirement, net
-
-
-
-
-
-
-
-
-
-
-
-
Other, net
-
-
-
-
-
-
-
-
-
-
-
-
Financial services
                                                  
Deferred income tax benefit
-
-
-
-
-
-
-
-
-
-
-
-
PMCC leveraged lease charge
-
-
-
-
-
-
-
-
-
-
-
-
Decrease to allowance for losses
-
-
-
-
-
-
-
-
-
-
-
-
Other liabilities (income taxes)
-
-
-
-
-
-
-
-
-
-
-
-
PMCC Leveraged Lease Charge
-
-
-
-
-
-
-
-
-
-
-
-
Other
-
-
-
-
-
-
-
-
-
-
-
-
Net cash provided by (used in) operating activities
719
2,324
3,094
205
2,720
2,611
(75)
2,877
2,952
124
2,984
3,076
Net cash provided by operating activities
-
-
-
-
-
-
-
-
-
-
-
-
Cash Provided by (Used in) Investing Activities
                                                  
Consumer products
                                                  
Capital expenditures
(57)
(93)
(54)
(32)
(38)
(31)
(29)
(35)
(40)
(48)
(55)
(64)
Proceeds from the ABI Transaction
-
-
-
-
0
-
-
2,353
-
-
-
-
Proceeds from the sale of IQOS System commercialization rights
-
-
-
-
-
-
-
-
1,700
-
-
-
Acquisition of NJOY, net of cash acquired
-
-
-
-
-
-
-
-
(1)
(2,750)
-
-
Investment in Cronos
-
-
-
-
-
-
-
-
-
-
-
-
Acquisition of businesses and assets
-
-
-
-
-
-
-
-
-
-
-
-
Proceeds from finance assets
-
-
-
-
-
-
-
-
-
-
-
-
Financial services
                                                  
Other, net
-
(16)
(6)
(4)
(5)
(10)
(8)
(2)
(18)
(4)
(1)
(1)
Net cash provided by (used in) investing activities
(57)
(109)
(60)
(36)
(43)
(41)
(37)
2,316
1,641
(2,802)
(56)
(65)
Net cash provided by (used in) investing activities
-
-
-
-
-
-
-
-
-
-
-
-
Cash Provided by (Used in) Financing Activities
                                                  
Long-term debt issued
-
0
995
-
997
-
-
-
-
-
-
-
Proceeds from short-term borrowings
-
-
-
-
-
-
-
-
-
2,000
-
-
Long-term debt repaid
-
(1,069)
-
(1,607)
0
-
-
(1,121)
-
(218)
(1,348)
(1,105)
Repayment of short-term borrowings
-
-
-
-
-
-
-
-
(2,000)
-
-
-
Consumer products
                                                  
Repurchases of common stock
(55)
(280)
(112)
(274)
(326)
(680)
(10)
(2,400)
(260)
(472)
0
(368)
Dividends paid on common stock
(1,776)
(1,780)
(1,721)
(1,724)
(1,730)
(1,688)
(1,687)
(1,733)
(1,675)
(1,682)
(1,683)
(1,629)
Premiums and fees related to early extinguishment of debt
-
-
-
-
-
-
-
-
-
-
-
-
Issuances of common stock
-
-
-
-
-
-
-
-
-
-
-
-
Financing fees and debt issuance costs
-
-
-
-
-
-
-
-
-
-
-
-
Other, net
-
(28)
(11)
(3)
(26)
(110)
(1)
(14)
-
(1)
(14)
(1)
Net cash provided by (used in) financing activities
(1,831)
(3,157)
(849)
(3,608)
(1,085)
(2,478)
(1,698)
(5,268)
(3,935)
(373)
(3,045)
(3,103)
Cash, cash equivalents and restricted cash:
                                                  
Net cash used in financing activities
-
-
-
-
-
-
-
-
-
-
-
-
Cash, cash equivalents and restricted cash:
                                                  
Increase (decrease)
$ (1,169)
$ (942)
$ 2,185
$ (3,439)
$ 1,592
$ 92
$ (1,810)
$ (75)
$ 658
$ (3,051)
$ (117)
$ (92)